Patents by Inventor Fabrice Leboeuf

Fabrice Leboeuf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210346441
    Abstract: There is described herein a non-replicating Rhabdovirus-derived particle that lacks the ability to spread between cells while having tropism against immortalized cells. The non-replicating Rhabdovirus-derived particle may have cytolytic tropism against immortalized cells. There is also described a non-replicating Rhabdovirus-derived particle that lacks the ability to spread between cells but has innate and/or adaptive immune-stimulating properties.
    Type: Application
    Filed: July 21, 2021
    Publication date: November 11, 2021
    Inventors: David Conrad, Cory Batenchuk, Fabrice Leboeuf, John Cameron Bell
  • Patent number: 11110138
    Abstract: There is described herein a non-replicating Rhabdovirus-derived particle that lacks the ability to spread between cells while having tropism against immortalized cells. The non-replicating Rhabdovirus-derived particle may have cytolytic tropism against immortalized cells. There is also described a non-replicating Rhabdovirus-derived particle that lacks the ability to spread between cells but has innate and/or adaptive immune-stimulating properties.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: September 7, 2021
    Assignee: CELVERUM INC.
    Inventors: David Conrad, Cory Batenchuk, Fabrice Leboeuf, John Cameron Bell
  • Patent number: 9782367
    Abstract: The present invention relates to a novel method for obtaining a pharmaceutical composition based on modafinil. This method consists of solubilizing S modafinil in a fluid in the supercritical state and then after expansion of said fluid, recovering S modafinil by causing it to be absorbed at the surface by a support appearing as granules. Said fluid may be CO2 or another solvent and the support, anhydrous lactose or mannitol. Application of the pharmaceutical composition in the cases when increased short term alertness and over a short period is required for the consumer of the pharmaceutical composition.
    Type: Grant
    Filed: February 25, 2013
    Date of Patent: October 10, 2017
    Assignee: DEBREGEAS ET ASSOCIES PHARMA
    Inventors: Christophe Lebon, Pascal Suplie, Fabrice Leboeuf, Jennifer Jung, Frantz Deschamps
  • Publication number: 20150320810
    Abstract: There is described herein a non-replicating Rhabdovirus-derived particle that lacks the ability to spread between cells while having tropism against immortalized cells. The non-replicating Rhabdovirus-derived particle may have cytolytic tropism against immortalized cells. There is also described a non-replicating Rhabdovirus-derived particle that lacks the ability to spread between cells but has innate and/or adaptive immune-stimulating properties.
    Type: Application
    Filed: December 20, 2013
    Publication date: November 12, 2015
    Inventors: David Conrad, Cory Batenchuk, Fabrice Leboeuf, John Cameron Bell
  • Publication number: 20150105470
    Abstract: The present invention relates to a novel method for obtaining a pharmaceutical composition based on modafinil. This method consists of solubilizing S modafinil in a fluid in the supercritical state and then after expansion of said fluid, recovering S modafinil by causing it to be absorbed at the surface by a support appearing as granules. Said fluid may be CO2 or another solvent and the support, anhydrous lactose or mannitol. Application of the pharmaceutical composition in the cases when increased short term alertness and over a short period is required for the consumer of the pharmaceutical composition.
    Type: Application
    Filed: February 25, 2013
    Publication date: April 16, 2015
    Inventors: Christophe Lebon, Pascal Suplie, Fabrice Leboeuf, Jennifer Jung, Frantz Deschamps
  • Patent number: 8765184
    Abstract: The present invention relates to a method for preparing solid pharmaceutical compositions comprising fine particles of at least one active substance, dispersed on and (or) within a divided solid. This method is characterized in that a solution is formed which comprises at least one active substance in a fluid at supercritical pressure, said solution then being expanded in a chamber under temperature and pressure conditions for which a part of said fluid is in the liquid state at the time of the expansion, said fluid thus expanded being brought into contact with a divided solid in said chamber.
    Type: Grant
    Filed: March 30, 2010
    Date of Patent: July 1, 2014
    Assignee: Stanipharm
    Inventors: Frantz Deschamps, Jennifer Jung, Fabrice Leboeuf
  • Publication number: 20120027852
    Abstract: A pharmaceutical formulation includes a Limus family immunosuppressive macrolide on a pharmaceutically acceptable excipient, which may be compounded as suitable for oral administration.
    Type: Application
    Filed: March 31, 2010
    Publication date: February 2, 2012
    Applicant: ETHYPHARM
    Inventors: Frantz Deschamps, Catherine Herry, Jennifer Jung, Fabrice Leboeuf
  • Publication number: 20120021021
    Abstract: The present invention relates to a method for preparing solid pharmaceutical compositions comprising fine particles of at least one active substance, dispersed on and (or) within a divided solid. This method is characterized in that a solution is formed which comprises at least one active substance in a fluid at supercritical pressure, said solution then being expanded in a chamber under temperature and pressure conditions for which a part of said fluid is in the liquid state at the time of the expansion, said fluid thus expanded being brought into contact with a divided solid in said chamber.
    Type: Application
    Filed: March 30, 2010
    Publication date: January 26, 2012
    Applicant: STANIPHARM
    Inventors: Frantz Deschamps, Jennifer Jung, Fabrice Leboeuf
  • Patent number: 7291296
    Abstract: The invention concerns a method for making very fine particles containing at least an active principle inserted in a host molecule and a device for implementing said method. The method is characterized in that it consists in forming a solution of the active principle in a first liquid solvent and of a product formed by the host molecules in a second liquid solvent, then in contacting the resulting solutions with a supercritical pressure fluid, so as to precipitate the host molecules which are dissolved therein.
    Type: Grant
    Filed: October 19, 2001
    Date of Patent: November 6, 2007
    Assignee: Separex (Societe Anonyme)
    Inventors: Michel Perrut, Jennifer Jung, Fabrice Leboeuf, Isabelle Fabing
  • Publication number: 20040119179
    Abstract: The invention concerns a method for making very fine particles containing at least an active principle inserted in a host molecule and a device for implementing said method. The method is characterized in that it consists in forming a solution of the active principle in a first liquid solvent and of a product formed by the host molecules in a second liquid solvent, then in contacting the resulting solutions with a supercritical pressure fluid, so as to precipitate the host molecules which are dissolved therein.
    Type: Application
    Filed: February 17, 2004
    Publication date: June 24, 2004
    Inventors: Michel Perrut, Jennifer Jung, Fabrice Leboeuf, Isabelle Fabing
  • Publication number: 20040110871
    Abstract: The invention concerns a method for obtaining solid particles from at least a water soluble product, characterized in that it comprises steps which consist in: forming a solution of said product in an aqueous phase, producing an emulsion, or a micro-emulsion, consisting of said aqueous mixture and a polar organic phase, contacting said emulsion, or said micro-emulsion, with a fluid at supercritical pressure, or a liquefied gas, so that the latter extracts the organic phase and the water, thereby precipitating the formed solid particles of the water soluble product, and collecting the resulting formed particles.
    Type: Application
    Filed: October 14, 2003
    Publication date: June 10, 2004
    Inventors: Michel Perrut, Jennifer Jung, Fabrice Leboeuf